Abnormal neurodevelopmental outcomes are common in children with transient congenital hyperinsulinism

Frontiers in Endocrinology

Volumn 4, Issue MAY, 2013, Pages

  Avatapalle, Hima Bindu ^a   Banerjee, Indraneel ^a   Shah, Sajni ^a   Pryce, Megan ^a   Nicholson, Jacqueline ^a   Rigby, Lindsey ^a   Caine, Louise ^a   Didi, Mohammed ^b   Skae, Mars ^a   Ehtisham, Sarah ^a   Patel, Leena ^a   Padidela, Raja ^a   Cosgrove, Karen E ^c   Dunne, Mark J ^c   Clayton, Peter E ^a  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Congenital hyperinsulinism; Developmental delay; Hypoglycemia; Neurodevelopment; Neurological outcome; Seizures; Transient congenital hyperinsulinism

Indexed keywords

DIAZOXIDE; GLUCAGON;

ARTICLE; CHILD; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HYPOGLYCEMIA; HYPSARRHYTHMIA; LANGUAGE DISABILITY; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NERVE CELL DIFFERENTIATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS RESECTION; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PRESCHOOL CHILD; SEIZURE; SPEECH DISORDER; VISUAL DISORDER;

EID: 84884176729     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00060     Document Type: Article

References (18)

1. Arnoux, J. B., Verkarre, V., Saint-Martin, C., Montravers, F., Brassier, A., Valayannopoulos, V., et al. (2012). Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet. J. Rare Dis. 6, 63.
2. Bahi-Buisson, N., Roze, E., Dionisi, C., Escande, F., Valayannopoulos, V., Feillet, F., et al. (2008). Neurological aspects of hyperinsulinism-hyperammonemia syndrome. Dev. Med. Child Neurol. 50, 945-949.
3. Banerjee, I., Skae, M., Flanagan, S. E., Rigby, L., Patel, L., Didi, M., et al. (2011). The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism. Eur. J. Endocrinol. 164, 733-740.
4. Gataullina, S., Dellatolas, G., Perdry, H., Robert, J. J., Valayannopoulos, V., Touati, G., et al. (2012). Comorbidity and metabolic context are crucial factors determining neurological sequelae of hypoglycaemia. Dev. Med. Child Neurol. 54, 1012-1017.
5. Gataullina, S., Lonlay, P. D., Dellatolas, G., Valayannapoulos, V., Napuri, S., Damaj, L., et al. (2013). Topography of brain damage in metabolic hypoglycaemia is determined by age at which hypoglycaemia occurred. Dev. Med. Child Neurol. 55, 162-166.
6. Gloyn, A. L., Diatloff-Zito, C., Edghill, E. L., Bellanne-Chantelot, C., Nivot, S., Coutant, R., et al. (2006). KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. Eur. J. Hum. Genet. 14, 824-830.
7. Huang, C. W., Wu, S. N., Cheng, J. T., Tsai, J. J., and Huang, C. C. (2010). Diazoxide reduces status epilepticus neuron damage in diabetes. Neurotox. Res. 17, 305- 316.
8. Kapoor, R. R., Flanagan, S. E., Fulton, P., Chakrapani, A., Chadefaux, B., Ben-Omran, T., et al. (2009). Hyperinsulinism-hyperammonemia syndrome: novel mutations in the GLUD1 gene and genotype-phenotype correlations. Eur. J. Endocrinol. 161, 731-735.
9. Kumaran, A., Kar, S., Kapoor, R. R., and Hussain, K. (2010). The clinical problem of hyperinsulinemic hypoglycemia and resultant infantile spasms. Pediatrics 126, e1231-6.
10. Ludwig, A., Ziegenhorn, K., Empting, S., Meissner, T., Marquard, J., Holl, R., et al. (2011). Glucose metabolism and neurological outcome in congenital hyperinsulinism. Semin. Pediatr. Surg. 20, 45-49.
11. Mazor-Aronovitch, K., Gillis, D., Lobel, D., Hirsch, H. J., Pinhas-Hamiel, O., Modan-Moses, D., et al. (2007). Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism. Eur. J. Endocrinol. 157, 491-497.
12. Meissner, T., Wendel, U., Burgard, P., Schaetzle, S., and Mayatepek, E. (2003). Long-term follow-up of 114 patients with congenital hyperinsulinism. Eur. J. Endocrinol. 149, 43-51.
13. Menni, F., de Lonlay, P., Sevin, C., Touati, G., Peigne, C., Barbier, V., et al. (2001). Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics 107, 476-479.
14. Ng, Y. T. (2012). The hitchhiker's guide to the role of (transient) hypoglycemia in refractory seizures and epilepsy. Pediatr. Neurol. 47, 123-124.
15. Senniappan, S., Shanti, B., James, C., and Hussain, K. (2012). Hyperinsulinaemic hypoglycaemia: genetic mechanisms, diagnosis and management. J. Inherit. Metab. Dis. 35, 589-601.
16. Tam, E. W., Haeusslein, L. A., Bonifacio, S. L., Glass, H. C., Rogers, E. E., Jeremy, R. J., et al. (2012). Hypoglycemia is associated with increased risk for brain injury and adverse neurodevelopmental outcome in neonates at risk for encephalopathy. J. Pediatr. 161, 88-93.
17. Vercellino, G. F., Cremonte, M., Carlando, G., Colivicchi, M., Crivelli, S., Ricotti, A., et al. (2011). Transient neonatal hyperinsulinemic hypoglycemia and neurological outcome: a case report. Minerva Pediatr. 63, 111-114.
18. Zhang, H., Zhao, D., Wang, Z., and Zheng, D. (2010). Diazoxide preconditioning alleviates caspase-dependent and caspase-independent apoptosis induced by anoxia -reoxygenation of PC12 cells. J. Biochem. 148, 413-421.